Smol'ianinov E S, Gol'dberg V E, Matiash M G, Ryzhakov V M, Boldyshev D A, Litvinenko V I, Dygaĭ A M
Institute of Pharmacology Tomsk Research Center, Russian Academy of Medical Sciences, Russia.
Eksp Klin Farmakol. 1997 Nov-Dec;60(6):49-51.
Cytostatic therapy of patients with lung cancer is attended with decrease in the relative number of T-lymphocytes and their theophylline-resistant population. Patients who were given SB showed a tendency towards increase of these parameters during antitumor chemotherapy. The immunoregulation index (IRI) in this case was approximately twice the background values during the whole period of investigation. The inclusion of SB in the therapeutic complex promotes increase in the number of immunoglobulins A at a stable level of immunoglobulins G.
